Figure 3.
FUS-mediated delivery of GDNF-BPN improves dopamine levels in the ipsilateral hemisphere. Bar graph of dopamine levels in the striatum in the ipsilateral (black) and contralateral (gray) hemisphere at weeks 2, 6, or 12 after 6-OHDA administration. n = 5 (6-OHDA + FUS + GDNF-BPN), n = 4 (6-OHDA only), or n = 3 in each group at each time point. *p < 0.05 vs all groups at the same time point and same hemisphere. **p < 0.05. +p < 0.05 vs contralateral at same time point.